145 related articles for article (PubMed ID: 11433190)
1. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
Martinez A; Salas E; Radomski A; Radomski MW
Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
7. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
8. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
10. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
11. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
Persson AA; Gunnarsson P; Lindström E; Grenegård M
Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
[TBL] [Abstract][Full Text] [Related]
12. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
13. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
14. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
15. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
Asplund Persson A; Zalavary S; Lindström E; Whiss PA; Bengtsson T; Grenegård M
Eur J Pharmacol; 2005 Jul; 517(3):149-57. PubMed ID: 15963495
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and platelet energy metabolism.
Tomasiak M; Stelmach H; Rusak T; Wysocka J
Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
20. Cardiac mitochondrial cGMP stimulates cytochrome c release.
Seya K; Motomura S; Furukawa K
Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
